Sinecatechins

Medically reviewed by
Prof. MD. Orhan Tanrıverdi Prof. MD. Orhan Tanrıverdi TEMP. Cancer
...
Views
Read Time

Drug Overview 

Sinecatechins is a botanical medication derived from the leaves of green tea (Camellia sinensis). It is a highly purified extract that contains a mixture of natural chemicals called catechins. These chemicals are potent antioxidants and have been found to have anti-viral and anti-tumor properties. Unlike many synthetic medicines, this drug is a complex mixture of organic compounds that work together to treat specific skin conditions.

In the world of oncology and dermatology, sinecatechins is recognized for its ability to target and clear abnormal skin growths caused by viral infections. It is a key example of how natural substances can be refined into professional, regulated medical treatments.

  • Generic name: Sinecatechins
  • US Brand names: Veregen
  • Drug Class: Botanical drug, Anti-viral (topical)
  • Route of Administration: Topical (applied to the skin as an ointment)
  • FDA Approval Status: FDA Approved

What Is It and How Does It Work? (Mechanism of Action)

Sinecatechins
Sinecatechins 2

Sinecatechins is considered a form of Targeted Therapy because of how it interacts with specific viral and cellular pathways. The primary active component is epigallocatechin gallate (EGCG), which acts as a “Smart Drug” by interfering with the survival of infected cells.

At the molecular level, sinecatechins works through several complex signaling pathways:

  1. Inhibition of Viral Replication: The catechins interfere with the Human Papillomavirus (HPV) by blocking the expression of viral “oncoproteins” known as E6 and E7. These proteins are the primary drivers that cause cells to grow abnormally. By shutting them down, the medication stops the virus from forcing the skin cells to multiply.
  2. Induction of Apoptosis: Sinecatechins triggers “programmed cell death” or apoptosis in the infected cells. It does this by modulating the PI3K/Akt and NF-kappaB signaling pathways. When these pathways are inhibited, the abnormal cells lose their ability to survive and naturally die off.
  3. Antioxidant and Anti-inflammatory Action: The drug blocks enzymes like cyclooxygenase (COX), which reduces the inflammation and swelling associated with skin lesions.
  4. Immune System Support: While primarily a targeted treatment, it also has Immunotherapy characteristics. It helps the body’s local immune cells recognize the virus more effectively, leading to a more robust natural defense against the infection.

FDA Approved Clinical Indications

Oncological uses

  • While not a primary treatment for internal cancers, it is used to treat external lesions that, if left untreated, could undergo malignant transformation in certain high-risk patients.

Non-oncological uses

  • Treatment of external genital and perianal warts (Condylomata acuminata) in immunocompetent patients aged 18 years and older.

Dosage and Administration Protocols

Sinecatechins is applied as an ointment directly to the affected area. It is important to follow the frequency exactly as prescribed to ensure the catechins stay active on the skin surface.

Application TypeStandard DosageFrequencyDuration of Treatment
Topical Ointment (15 percent)0.5 centimeter strand per wartThree times per dayUntil complete clearance (up to 16 weeks)

Dose Adjustments

Because this medication is applied topically and has very low absorption into the bloodstream, no dose adjustments are required for patients with renal (kidney) or hepatic (liver) insufficiency. However, it should only be used on external skin surfaces and not on open wounds or internal membranes.

Clinical Efficacy and Research Results

Clinical research data from 2020 to 2025 has confirmed that sinecatechins remains a highly effective option for viral skin lesions. Numerical data from large clinical trials show that complete clearance of all warts occurs in approximately 50 percent to 60 percent of patients within the 16-week treatment window.

Interestingly, the “recurrence rate” (the chance of the growths coming back) is significantly lower with sinecatechins compared to other treatments like freezing (cryotherapy). Studies show that once the lesions are cleared by sinecatechins, less than 10 percent of patients see a return of the condition within the first 12 weeks of follow-up. This suggests that the drug’s ability to modulate the local immune environment provides a long-lasting protective effect.

Safety Profile and Side Effects

Sinecatechins is generally well-tolerated, though local skin reactions are very common as the drug begins to work on the infected tissue.

Black Box Warning

There is no Black Box Warning for sinecatechins.

Common side effects

These effects occur at the site of application in more than 10 percent of patients:

  • Redness (erythema)
  • Itching (pruritus)
  • Burning sensation
  • Pain or tenderness
  • Swelling (edema)

Serious adverse events

  • Severe skin ulceration or breakdown
  • Severe allergic contact dermatitis (intense rash or hives)
  • Lymphadenopathy (swollen lymph nodes near the treatment area)

Management strategies

Most common side effects like redness and itching are “expected” signs that the medication is working. If the skin becomes too painful or starts to break open (ulceration), patients should wash the ointment off with mild soap and water and skip doses for a few days until the skin heals. Applying a thick layer is not necessary; a thin film is sufficient and reduces the risk of severe irritation.

Research Areas

Sinecatechins is a major focus in Research Areas involving the prevention of skin cancers. Because it can inhibit the E6 and E7 proteins of the HPV virus, researchers are studying whether it can prevent “precancerous” lesions from turning into Squamous Cell Carcinoma. Additionally, there is interest in the field of regenerative medicine regarding how green tea catechins can help skin heal without scarring after a tumor is surgically removed. Scientists are also looking at combining sinecatechins with local immunotherapy creams to see if they can create a “synergistic” effect to clear even the most stubborn viral infections.

Patient Management and Practical Recommendations

Pre-treatment tests to be performed

  • A visual diagnosis by a healthcare professional to confirm the lesions are warts and not a different type of skin growth.
  • A check for any known allergies to green tea or the ingredients in the ointment (like isopropyl myristate).

Precautions during treatment

The ointment can weaken condoms and diaphragms, so sexual contact should be avoided while the ointment is on the skin. It can also stain clothing and bedding, so wearing loose-fitting protective clothing is recommended.

Do’s and Don’ts list

  • Do wash your hands thoroughly before and after applying the ointment.
  • Do continue treatment for the full duration, even if the warts disappear early.
  • Do use a very small amount—just enough to cover each wart.
  • Don’t apply the ointment into the vagina, rectum, or urethra.
  • Don’t wash the ointment off immediately after application; wait until your next scheduled dose.
  • Don’t use occlusive dressings (like airtight bandages) over the treated area.

Legal Disclaimer

This medical information is provided for educational purposes only and does not replace the advice of a healthcare professional. Sinecatechins is a prescription medication and should only be used as directed by a doctor. If you experience a severe allergic reaction or extreme skin pain, seek medical attention immediately.

Trusted Worldwide
30
Years of
Experience
30 Years Badge

With patients from across the globe, we bring over three decades of medical

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Our Doctors

Op. MD. Selda Atar Akal

Op. MD. Selda Atar Akal

Psyc. Tuğba Annaç

Psyc. Tuğba Annaç

Prof. MD. Gönül Çatlı

Prof. MD. Gönül Çatlı

Asst. Prof. MD. Ayşe Deniz Akkaya

Asst. Prof. MD. Ayşe Deniz Akkaya

Asst. Prof. MD. Kübra Irmak

Prof. MD.  Rıfat Rasier

Prof. MD. Rıfat Rasier

Prof. MD. Hakan Uçar

Prof. MD. Hakan Uçar

Prof. MD. Nuri Faruk Aykan

Prof. MD. Nuri Faruk Aykan

Prof. MD.  Batur Gönenç Kanar

Prof. MD. Batur Gönenç Kanar

MD.  EMİN BAYRAMOV

MD. EMİN BAYRAMOV

Assoc. Prof. MD. Engin Çetin

Assoc. Prof. MD. Engin Çetin

Op. MD. Merve Evrensel

Op. MD. Merve Evrensel